Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature.

For unresectable locally advanced penile squamous cell carcinoma, neoadjuvant immunotherapy combined with chemotherapy is a potential treatment approach. Biomarkers of immunotherapy efficacy need to be explored, and clinical trials are needed to test these strategies.